LSTA logo

Lisata Therapeutics (LSTA) Cash From Investing

Annual CFI

$10.10 M
-$18.81 M-65.06%

31 December 2023

LSTA Cash From Investing Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly CFI

-$6.30 M
-$18.02 M-153.83%

30 September 2024

LSTA Quarterly CFI Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM CFI

$6.13 M
-$18.56 M-75.17%

30 September 2024

LSTA TTM CFI Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

LSTA Cash From Investing Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-65.1%-151.5%-73.3%
3 y3 years+238.8%-227.6%+108.7%
5 y5 years+314.6%-217.3%-59.3%

LSTA Cash From Investing High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years-65.1%+118.4%-124.6%at low-85.0%+108.7%
5 y5 years-65.1%+118.4%-124.6%+90.3%-85.0%+107.1%
alltimeall time-75.5%+118.4%-123.3%+90.3%-85.2%+107.1%

Lisata Therapeutics Cash From Investing History

DateAnnualQuarterlyTTM
Sept 2024
-
-$6.30 M(-153.8%)
$6.13 M(-75.2%)
June 2024
-
$11.71 M(+82.0%)
$24.69 M(+101.5%)
Mar 2024
-
$6.44 M(-212.6%)
$12.25 M(+21.3%)
Dec 2023
$10.10 M(-65.1%)
-$5.71 M(-146.6%)
$10.10 M(-55.9%)
Sept 2023
-
$12.25 M(-1789.9%)
$22.92 M(+77.3%)
June 2023
-
-$725.00 K(-116.9%)
$12.93 M(-67.1%)
Mar 2023
-
$4.29 M(-39.6%)
$39.29 M(+35.9%)
Dec 2022
$28.91 M(-152.7%)
$7.11 M(+214.3%)
$28.91 M(-24.4%)
Sept 2022
-
$2.26 M(-91.2%)
$38.26 M(-6.5%)
June 2022
-
$25.63 M(-520.9%)
$40.94 M(+897.6%)
Mar 2022
-
-$6.09 M(-137.0%)
$4.10 M(-107.5%)
Dec 2021
-$54.90 M(+654.4%)
-
-
Dec 2021
-
$16.46 M(+233.2%)
-$54.90 M(-22.1%)
Sept 2021
-
$4.94 M(-144.1%)
-$70.44 M(-18.5%)
June 2021
-
-$11.20 M(-82.8%)
-$86.43 M(+3.5%)
Mar 2021
-
-$65.09 M(-7252.7%)
-$83.47 M(+1047.0%)
Dec 2020
-$7.28 M(-134.0%)
$910.00 K(-108.2%)
-$7.28 M(+152.3%)
Sept 2020
-
-$11.04 M(+33.9%)
-$2.88 M(-121.3%)
June 2020
-
-$8.25 M(-174.3%)
$13.54 M(-43.1%)
Mar 2020
-
$11.10 M(+109.4%)
$23.79 M(+11.0%)
Dec 2019
$21.43 M(-555.3%)
$5.30 M(-1.4%)
$21.43 M(+42.3%)
Sept 2019
-
$5.38 M(+167.4%)
$15.06 M(+179.2%)
June 2019
-
$2.01 M(-77.0%)
$5.39 M(+3.3%)
Mar 2019
-
$8.74 M(-920.0%)
$5.22 M(-211.0%)
Dec 2018
-$4.71 M(-111.4%)
-$1.07 M(-75.2%)
-$4.71 M(-132.3%)
Sept 2018
-
-$4.29 M(-333.3%)
$14.59 M(-3.3%)
June 2018
-
$1.84 M(-254.7%)
$15.09 M(-62.5%)
Mar 2018
-
-$1.19 M(-106.5%)
$40.25 M(-2.5%)
Dec 2017
$41.27 M(-1548.5%)
$18.23 M(-580.7%)
$41.27 M(+83.4%)
Sept 2017
-
-$3.79 M(-114.0%)
$22.50 M(-12.4%)
June 2017
-
$27.00 M(<-9900.0%)
$25.68 M(-1399.9%)
Mar 2017
-
-$171.30 K(-67.9%)
-$1.98 M(-30.7%)
Dec 2016
-$2.85 M(-175.0%)
-$533.50 K(-12.9%)
-$2.85 M(-218.5%)
Sept 2016
-
-$612.50 K(-7.0%)
$2.40 M(-1839.3%)
June 2016
-
-$658.50 K(-37.0%)
-$138.20 K(-96.5%)
Mar 2016
-
-$1.04 M(-122.1%)
-$3.95 M(-204.0%)
Dec 2015
$3.80 M(-135.4%)
$4.72 M(-249.6%)
$3.80 M(-146.8%)
Sept 2015
-
-$3.15 M(-29.5%)
-$8.11 M(+56.1%)
June 2015
-
-$4.47 M(-166.7%)
-$5.20 M(+86.0%)
Mar 2015
-
$6.70 M(-193.3%)
-$2.79 M(-74.0%)
Dec 2014
-$10.74 M(+298.9%)
-$7.19 M(+2905.6%)
-$10.74 M(+103.0%)
Sept 2014
-
-$239.20 K(-88.4%)
-$5.29 M(-7.7%)
June 2014
-
-$2.07 M(+66.9%)
-$5.73 M(+47.8%)
Mar 2014
-
-$1.24 M(-28.9%)
-$3.88 M(+44.1%)
Dec 2013
-$2.69 M(-144.2%)
-$1.74 M(+156.3%)
-$2.69 M(-134.4%)
Sept 2013
-
-$680.10 K(+216.3%)
$7.83 M(-3.8%)
June 2013
-
-$215.00 K(+301.1%)
$8.14 M(+32.4%)
Mar 2013
-
-$53.60 K(-100.6%)
$6.14 M(+0.9%)
Dec 2012
$6.09 M(-396.3%)
$8.78 M(-2463.7%)
$6.09 M(-477.0%)
Sept 2012
-
-$371.30 K(-83.2%)
-$1.61 M(-179.0%)
June 2012
-
-$2.21 M(+1904.3%)
$2.05 M(+117.6%)
Mar 2012
-
-$110.10 K(-110.3%)
$939.90 K(-145.7%)
DateAnnualQuarterlyTTM
Dec 2011
-$2.05 M(-88.0%)
$1.07 M(-67.4%)
-$2.05 M(-77.7%)
Sept 2011
-
$3.29 M(-199.3%)
-$9.21 M(-40.5%)
June 2011
-
-$3.31 M(+6.7%)
-$15.49 M(-0.7%)
Mar 2011
-
-$3.10 M(-49.0%)
-$15.59 M(-8.9%)
Dec 2010
-$17.11 M(+545.3%)
-$6.09 M(+103.9%)
-$17.11 M(+33.7%)
Sept 2010
-
-$2.98 M(-12.6%)
-$12.80 M(+20.7%)
June 2010
-
-$3.41 M(-26.1%)
-$10.60 M(+46.0%)
Mar 2010
-
-$4.62 M(+159.6%)
-$7.26 M(+174.0%)
Dec 2009
-$2.65 M(>+9900.0%)
-$1.78 M(+125.2%)
-$2.65 M(+210.5%)
Sept 2009
-
-$790.40 K(+949.7%)
-$853.90 K(+866.0%)
June 2009
-
-$75.30 K(+1221.1%)
-$88.40 K(+574.8%)
Mar 2009
-
-$5700.00(-132.6%)
-$13.10 K(+33.7%)
Dec 2008
-$9800.00(-106.4%)
$17.50 K(-170.3%)
-$9800.00(-105.1%)
Sept 2008
-
-$24.90 K(<-9900.0%)
$192.50 K(+13.3%)
June 2008
-
$0.00(-100.0%)
$169.90 K(+5.3%)
Mar 2008
-
-$2400.00(-101.1%)
$161.40 K(+5.4%)
Dec 2007
$153.10 K(-455.2%)
$219.80 K(-562.7%)
$153.10 K(-258.2%)
Sept 2007
-
-$47.50 K(+458.8%)
-$96.80 K(+55.1%)
June 2007
-
-$8500.00(-20.6%)
-$62.40 K(+15.8%)
Mar 2007
-
-$10.70 K(-64.5%)
-$53.90 K(+24.8%)
Dec 2006
-$43.10 K(<-9900.0%)
-$30.10 K(+129.8%)
-$43.20 K(+229.8%)
Sept 2006
-
-$13.10 K(<-9900.0%)
-$13.10 K(<-9900.0%)
June 2006
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2006
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2005
$0.00(-100.0%)
$0.00(0.0%)
$0.00(-100.0%)
Sept 2005
-
$0.00(0.0%)
$600.00(>+9900.0%)
June 2005
-
$0.00(0.0%)
$0.00(-100.0%)
Mar 2005
-
$0.00(-100.0%)
-$2200.00(-33.3%)
Dec 2004
-$3300.00(-100.4%)
$600.00(-200.0%)
-$3300.00(-101.9%)
Sept 2004
-
-$600.00(-72.7%)
$171.10 K(-79.8%)
June 2004
-
-$2200.00(+100.0%)
$846.70 K(-0.0%)
Mar 2004
-
-$1100.00(-100.6%)
$846.90 K(-0.1%)
Dec 2003
$847.40 K(-167.9%)
$175.00 K(-74.1%)
$847.40 K(-202.0%)
Sept 2003
-
$675.00 K(<-9900.0%)
-$831.00 K(-44.7%)
June 2003
-
-$2000.00(+233.3%)
-$1.50 M(+0.1%)
Mar 2003
-
-$600.00(-100.0%)
-$1.50 M(+20.3%)
Dec 2002
-$1.25 M(-443.7%)
-$1.50 M(<-9900.0%)
-$1.25 M(+229.5%)
Sept 2002
-
$3800.00(>+9900.0%)
-$378.60 K(+8130.4%)
June 2002
-
$0.00(-100.0%)
-$4600.00(-101.6%)
Mar 2002
-
$252.20 K(-139.7%)
$287.10 K(-20.9%)
Dec 2001
$362.90 K(-1534.4%)
-$634.60 K(-268.0%)
$363.00 K(-74.5%)
Sept 2001
-
$377.80 K(+29.5%)
$1.43 M(-21.4%)
June 2001
-
$291.70 K(-11.1%)
$1.82 M(+19.6%)
Mar 2001
-
$328.10 K(-23.4%)
$1.52 M(-6096.4%)
Dec 2000
-$25.30 K(-94.6%)
$428.40 K(-44.1%)
-$25.30 K(-94.4%)
Sept 2000
-
$766.90 K(<-9900.0%)
-$453.70 K(-62.8%)
June 2000
-
-$6300.00(-99.5%)
-$1.22 M(+0.5%)
Mar 2000
-
-$1.21 M
-$1.21 M
Dec 1999
-$464.40 K(-32.8%)
-
-
Dec 1998
-$690.90 K(<-9900.0%)
-
-
Mar 1998
$0.00(0.0%)
-
-
Mar 1997
$0.00(-100.0%)
-
-
Mar 1996
-$5900.00
-
-

FAQ

  • What is Lisata Therapeutics annual cash flow from investing activities?
  • What is the all time high annual CFI for Lisata Therapeutics?
  • What is Lisata Therapeutics annual CFI year-on-year change?
  • What is Lisata Therapeutics quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Lisata Therapeutics?
  • What is Lisata Therapeutics quarterly CFI year-on-year change?
  • What is Lisata Therapeutics TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Lisata Therapeutics?
  • What is Lisata Therapeutics TTM CFI year-on-year change?

What is Lisata Therapeutics annual cash flow from investing activities?

The current annual CFI of LSTA is $10.10 M

What is the all time high annual CFI for Lisata Therapeutics?

Lisata Therapeutics all-time high annual cash flow from investing activities is $41.27 M

What is Lisata Therapeutics annual CFI year-on-year change?

Over the past year, LSTA annual cash flow from investing activities has changed by -$18.81 M (-65.06%)

What is Lisata Therapeutics quarterly cash flow from investing activities?

The current quarterly CFI of LSTA is -$6.30 M

What is the all time high quarterly CFI for Lisata Therapeutics?

Lisata Therapeutics all-time high quarterly cash flow from investing activities is $27.00 M

What is Lisata Therapeutics quarterly CFI year-on-year change?

Over the past year, LSTA quarterly cash flow from investing activities has changed by -$18.56 M (-151.46%)

What is Lisata Therapeutics TTM cash flow from investing activities?

The current TTM CFI of LSTA is $6.13 M

What is the all time high TTM CFI for Lisata Therapeutics?

Lisata Therapeutics all-time high TTM cash flow from investing activities is $41.27 M

What is Lisata Therapeutics TTM CFI year-on-year change?

Over the past year, LSTA TTM cash flow from investing activities has changed by -$16.79 M (-73.26%)